Bio-Path Holdings Reports Second Quarter 2020 Financial Results
HOUSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery […]
SCWorx Announces appointment of Timothy Hannibal, Seasoned Technology Executive and Entrepreneur, as President, Chief Operating Officer and Director
NEW YORK, Aug. 14, 2020 (GLOBE NEWSWIRE) — August 14, 2020, SCWorx Corp. (Nasdaq: WORX) announced today the appointment of […]
PLx Pharma Inc. Reports Second Quarter 2020 Results and Provides Business Update
–Bioequivalence study of VAZALORE 325 mg on track with top-line data demonstrating bioequivalence to immediate release aspirin––Shifting the date of […]
TLC Submits Investigational New Drug (IND) Application for TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
1% of oral dose for 30-fold lung exposure and reduced cardiotoxicityA cost-effective, easily accessible, user-friendly potential treatment/prevention optionSOUTH SAN FRANCISCO, […]
Marathon Patent Group Announces $23 Million Contract with Bitmain to Purchase 10,500 S-19 Pro Miners
LAS VEGAS, Aug. 14, 2020 (GLOBE NEWSWIRE) — Marathon Patent Group, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), a Nasdaq-listed cryptocurrency mining […]
Hooker Furniture to Host Second Quarter Earnings Call September 3
MARTINSVILLE, Va., Aug. 14, 2020 (GLOBE NEWSWIRE) — Hooker Furniture Corporation (Nasdaq-GS:HOFT) will present its fiscal 2021 second quarter financial […]
U.S. Energy Corp. Announces Second Quarter Financial and Operating Results
HOUSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) — U.S. Energy Corp. (NASDAQCM: USEG) (“We”, “U.S. Energy” or the “Company”) today announced […]
Enstar and Stone Point Capital Announce Exchange Transaction Involving Atrium and StarStone U.S.
HAMILTON, Bermuda, Aug. 14, 2020 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ: ESGR) (“Enstar”) today announced an exchange agreement with […]
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020
Completed $200 million private placement post periodPhase 3 COPD clinical trials planned to start later this yearPilot clinical study in […]
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate
UK government to purchase 60 million doses of NVX-CoV2373Novavax to partner with FUJIFILM Diosynth Biotechnologies to manufacture antigen component of […]
